Mayer Davidson to Costs and Cost Analysis
This is a "connection" page, showing publications Mayer Davidson has written about Costs and Cost Analysis.
Connection Strength
0.228
-
Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs. Diabetes Obes Metab. 2020 05; 22(5):719-721.
Score: 0.168
-
Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
Score: 0.060